Safety and Effectiveness of the AcuFocus Corneal Inlay ACI7000PDT in Presbyopes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01352442|
Recruitment Status : Completed
First Posted : May 11, 2011
Results First Posted : September 18, 2015
Last Update Posted : March 28, 2017
|Condition or disease||Intervention/treatment||Phase|
|Presbyopia||Device: AcuFocus Corneal Inlay ACI 7000PDT||Not Applicable|
The design and mechanism of action of the AcuFocus™ Corneal Inlay (ACI 7000PDT) is based on the well-established concept of small-aperture optics. In cameras, depth of focus is controlled by reducing the aperture through which light enters; the smaller the aperture, the greater the depth of focus. This concept also applies to the human eye. In the eye of an emmetropic presbyope, the natural lens cannot fully accommodate to focus the light rays from a near object onto a single point on the retina. Thus, a point object is imaged as a blur circle on the retina, and images of extended objects are degraded as well. If an opaque disc with a small aperture in the center is placed in front of the eye, the peripheral rays will be obscured while the central rays pass unaffected. Since peripheral rays enter the eye at a larger angle, they create a larger blur circle at the retinal image plane. Eliminating these peripheral rays reduces the size of the blur circle, improving image resolution.
When the inlay is implanted in one eye, the increased depth of focus provides near and intermediate visual acuity while having a minimal effect on distance acuity. Under binocular conditions, the effect of having an inlay eye with a range of vision from distance to near combined with the uncorrected vision in the fellow presbyopic eye, which will essentially have good distance acuity with reduced near acuity, is similar to the contact lens modality known as "modified monovision."
The ACI is expected to provide presbyopic patients with improvement in near and intermediate vision.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||151 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Prospective Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the AcuFocus Corneal Inlay ACI 7000PDT Implanted Intrastromally for Modified Monovision in Presbyopic Subjects|
|Study Start Date :||May 2011|
|Actual Primary Completion Date :||March 2014|
|Actual Study Completion Date :||March 2014|
Experimental: AcuFocus Corneal Inlay
The AcuFocus Corneal Inlay ACI 7000PDT, which is a small medical device, will be surgically implanted in one eye of each subject.
Device: AcuFocus Corneal Inlay ACI 7000PDT
Other Name: AcuFocus KAMRA inlay
- Uncorrected Near Visual Acuity 20/32 or Better [ Time Frame: 12 months ]
- Subjective Rating of Near Visual Acuity at 12 Months as Measured by Subjective Questionnaire [ Time Frame: 12 months ]Mean subjective rating via questionnaire on 1 to 7 rating scale (1= very dissatisfied and 7 = very satisfied).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01352442
|Australia, New South Wales|
|Vision Eye Institute|
|Bondi Junction, New South Wales, Australia, 2022|
|Univ. Klinik fur Agugenheilkunde und Optometrie, Paracelsus Medzinishe Privatuniversitat Salzburg|
|Salzburg, Austria, A-5020|
|Paris, France, 75019|
|Shinagawa Lasik Center|
|Maastricht University Medical Center|
|Maastricht, Netherlands, 6229|
|The Fendalton Eye Clinic|
|Fendalton, Christchurch, New Zealand|
|Auckland, New Zealand|
|Asian Eye Institute|
|Makati City, Philippines, 1200|
|Singapore National Eye Centre|
|Singapore, Singapore, 168751|
|CEIC Vissum Corporación Oftalmológica|
|Alicante, Spain, 03016|
|Beyoğlu Goz Training and Research Hospital|
|Study Director:||Perry Binder, MD|